Thrombotic thrombo-cytopenic purpura associated with histamine H2-receptor antagonist therapy.
Kallal
S M
SM
Dept of Medicine, University of Texas Health Science Center, San Antonio 78284-7878, USA.
Lee
M
M
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D015738:Famotidine / Q000009:adverse effects* / Q000627:therapeutic use; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006635:Histamine H2 Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy
D000305:Adrenal Cortex Hormones; D006635:Histamine H2 Antagonists; D015738:Famotidine